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ABSTRACT
The human immunodeficiency virus integrase (HIV IN)
protein cleaves two nucleotides off the 3' end of viral
DNA and subsequently integrates the viral DNA into
target DNA. IN exposes a specific phosphodiester bond
near the viral DNA end to nucleophilic attack by water
or other nucleophiles, such as glycerol or the 3'
hydroxyl group of the viral DNA molecule itself. Wild-
type IN has a preference for water as the nucleophile;
we here describe a class of IN mutants that
preferentially use the 3' hydroxyl group of viral DNA
as nucleophile. The amino acids that are altered in this
class of mutants map near the putative active-site
residues Asp-i 16 and Glu-152. These results support
a model in which multiple amino acid side-chains are
involved in presentation of the (soluble) nucleophile.
IN is probably active as an oligomeric complex, in
which the subunits have non-equivalent roles; we here
report that nucleophile selection is determined by the
subunit that supplies the active site.
INTRODUCTION
After reverse transcription of the HIV genomic RNA, the viral
cDNA is integrated into the human chromosome. Integration is
catalyzed by the viral IN protein. IN first removes two nucleotides
from the blunt-ended viral DNA (1, 2), and subsequently couples
the newly formed 3' hydroxyl ends to phosphate groups in the
target DNA (3-5).
Site-specific cleavage of the viral DNA is probably a one-step
reaction: the phosphodiester bond 3' of the conserved CA
dinucleotide near the viral DNA end is exposed to nucleophilic
attack (figure 1; ref. 6, 7). The natural nucleophile is most likely
water, resulting in the release of a dinucleotide with a 5'
phosphate and a 3' hydroxyl group. In vitro however, other
nucleophiles can also be used, such as the alcohol glycerol,
resulting in formation of a linear dinucleotide with a glycerol
group coupled to the 5' phosphate group (this reaction is called
alcoholysis; ref. 7), or the 3' hydroxyl group of the viral DNA,
resulting in formation of a circular dinucleotide in which the 3'
hydroxyl group is coupled to the 5' phosphate group (6).
Mutational analysis identified three candidate active-site
residues in the HIV IN protein: Asp-64, Asp-i 16, and Glu-152
(8-12). These residues are conserved in all retroviral IN proteins
(13, 14); proteins in which any one of these residues is mutated
are inactive. Mutation of residues around Asp-i 16 and Glu-152
resulted in reduced activity. The active site is most likely
contained in a polypeptide of amino acids 50 to 186 (15, 16);
deletion mutants comprising these residues are able to mediate
disintegration (the reverse of integration; ref. 17). One mutation
in this region (Asn-1 17- Gln of HIV-1 IN) was found to cause
a preference for the 3' hydroxyl end of viral DNA as the
nucleophile in the donor cut reaction (9). We here report the
characterization of a whole class of mutants of HIV-2 IN
(mapping around Asp-i 16 and Glu-152) that have the
characteristic that they use the 3' viral DNA end instead of water
(or glycerol) as nucleophile. When substrates are presented that
do not allow the formation of a circular dinucleotide, or when
reaction conditions are chosen that do not support the formation
of circular dinucleotides (Mg2+ instead of Mn2+), the cleavage
activity of these mutants is severely reduced.
The C-terminus of IN contains a DNA-binding domain, located
between amino acids 200 and 270 (16), which is required for
site-specific cleavage and integration, but not disintegration. IN
mutants that are inactivated by mutations in different domains
can complement each other (19,20), suggesting that IN is active
as an oligomer (21) in which the subunits play non-equivalent
roles. For example, the C-terminal DNA-binding domain and
the central catalytic domain can be supplied on different
molecules, suggesting that one subunit binds (viral) DNA, and
another mediates cleavage of that DNA. We found that
nucleophile selection is determined by the subunit that contains
the intact active site.
MATERIALS AND METHODS
DNA techniques
DNA techniques were as described (22). Site-directed muta-
genesis of the HIV-2 IN gene was done as described (12). Double
mutant CA73/Q148L was made by site-directed mutagenesis of
the construct expressing CA73, using oligonucleotide
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5'-ACTACTCCTAGGCTCTGTG-3'. Mutant D64V/Q148L
was made by cloning the MscI-HindHI fragment carrying the
mutation Q148L into the MscI and HindH sites of the construct
expressing D64V.
Oligonucleotide cleavage reactions were carried out as
described with substrates that were either labeled at the 3' end
(7), or the 5' end (12). The reaction products were separated
by denaturing polyacrylamide gelelectrophoresis and visualized
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Figure 1. Schematic representation of site-specific cleavage b
position of the 32p label is depicted by a circle.
A
by autoradiography. Autoradiographs were scanned using an
Ultrascan XL Enhanced Laser Densitometer (LKB).
Protein expression and purification
HIV-2 IN protein was expressed in E.coli and purified as
described (12). Complementation assays were carried out as
described (21).
RESULTS
Mutants with a different preference for nucleophiles
HIV IN cleaves two nucleotides off the 3' ends of viral DNA
GCA by exposing the phosphodiester bond to nucleophilic attack by
water, glycerol, or the 3' hydroxyl group of the viral DNA
(resulting in the formation of a linear dinucleotide, a linear
dinucleotide with a glycerol group covalently coupled to the 5'
hydrolysisPrOdUct phosphate group, or a circular dinucleotide, respectively;
figure 2A lane 3).
khpfodtJd We searched for mutants that have a different preference for
nucleophiles. We therefore constructed and assayed a set of 31
HIV-2 IN mutants in which one amino acid had been changed
drculardinuleodde (most of them described in ref. 12). We found that most mutants
produced similar relative amounts of the three cleavage products
(figure 2B). However, several mutants produced relatively more
circular dinucleotides (figure 2A and table 1). We will refer to
y HIV IN. The these mutants as alcoholysis mutants. The most striking example
is mutant Q148L, which produces almost exclusively circular
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Figure 2. Alcoholysis mutants. (A) Cleavage reactions using oligonucleotide substrates labeled at the 3' end. The positions of the 28-mer substrate (28), glycerol
adduct (G), circular dinucleotide (C), and (linear) dinucleotides (D) are indicated on the left. The various HIV-2 IN mutants used are indicated above the lanes.
-IN = without IN, DNase = DNaseI degradation ladder of the oligonucleotide used in the cleavage reactions, WT wild-type HIV-2 IN. The nomenclature
of mutants is as follows: the first letter signifies the residue in wild-type HIV-2 IN, followed by its position and the amino acid to which it has been changed. (B)
Diagram showing the relative amounts of circular dinucleotides produced by the various HIV-2 IN mutants. On the X-axis the position of the mutation is indicated,
and on the Y-axis the amount of circular dinucleotides as percentage of the total amount of cleavage products. The stippled line signifies the relative amount of
circular dinucleotides produced by wild-type HIV-2 IN. The positions of the putative active-site residues Asp-64, Asp-116 and Glu-152 are depicted by arrows.
The following mutants were tested: H12L, C40S, K46L, T66A, K71L, S81A, K103Q, H114S, T115V, N117I, N117S, N120L, K127T, P142V, Y143L, N144V,
Q146A, S147A, Q148L, Q148S, V15OS, K159V, K186Q, R199S, K219Q, R2281, K236S, K244S, K258L, R263S, R269I. When two substitutions at the same
position were tested, the average amount of circular dinucleotides is shown in the diagram.
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dinucleotides (91% of the total amount of cleavage products,
compared to 16% for wild-type HIV-2 IN. The cleavage activity
of this mutant (i.e. the total amount of linear dinucleotides,
glycerol adducts, and circular dinucleotides produced) is lower
than that of wild-type HIV-2 IN. However, most other mutants
of this class are not significantly less active than wild-type protein,
but produce a higher amount of circular dinucleotides. These
mutations therefore do not affect the ability for donor cleavage
per se, but only the choice of the nucleophile. We found mutations
in six different residues that resulted in production of a relatively
higher amount of circular dinucleotides. Two of these amino acids
map around the active-site residue Asp-1 16 (His-1 14 and
Asn-1 17), and four are clustered close to the active-site residue
Glu-152 (Tyr-143, Gln-146, Ser-147, and Gln-148).
The majority of the amino acid substitutions originally
investigated were from hydrophilic to hydrophobic residues. We
originally changed Asn-1 17 and Gln-148 to the hydrophobic
amino acids isoleucine and leucine respectively. To investigate
whether hydrophobicity of this region determines the choice of
nucleophiles, we also changed Asn-1 17 and Gln-148 to the polar
amino acid serine. We found that substitution by hydrophobic
residues resulted in production of a somewhat higher percentage
of circular dinucleotides than substitution by the polar amino acid
serine, but in both cases there was a marked increase in the
relative amount of circular dinucleotides compared to wild-type.
This shows that hydrophobicity of these residues is not the main
factor determining the choice of nucleophile.
Wild-type HIV-2 IN produced approximately twice as much
linear as glycerol product (57% versus 27%; table 1). Some
mutations resulted in a somewhat different ratio between these
two products (e.g. mutant S147A produces 5 times more linear
dinucleotides than glycerol products; table 1).
Alcoholysis mutants have a reduced site-specific cleavage
activity when formation of circular dinucleotides is impossible
All experiments described above have been done under conditions
that allow use of the viral 3' hydroxyl group as nucleophile. We
investigated whether mutants that have a preference for the viral
3' hydroxyl group as nucleophile would use soluble nucleophiles
under conditions that do not allow use of the 3' hydroxyl end
of viral DNA. This can be accomplished by changing the assay
conditions (substituting Mg2+ for Mn2+), or use of substrates
Table 1. Point mutants in the catalytic domain.
mutant total linear glycerol circular
wild type 100 57 27 16
H114S 79 39 16 44
N117I 75 21 18 60
N117S 79 31 15 54
N120L 92 75 18 7
Y143L 80 21 17 62
Q146A 87 28 11 61
S147A 126 23 5 72
Q148L 29 6 3 91
Q148S 54 21 5 74
The autoradiograph of Figure 1A was scanned and the amounts of linear
dinucleotides, glycerol products and circular dinucleotides were determined. The
second column shows the total amount of cleavage products as percentage of
cleavage products produced by wild-type HIV-2 IN, columns 3, 4, and 5 show
the amount of linear dinucleotides, glycerol products, and circular dinucleotides,
expressed as percentage of the total amount of cleavage products.
that do not allow formation of circular dinucleotides (e.g.
substrates in which one or three nucleotides are cleaved off; see
also ref. 7).
When Mn2+ is replaced by Mg2+, wild-type HIV-2 IN
cleaves the viral DNA end, but does not form circular
dinucleotides and formation of the glycerol adduct is less efficient
(compare figure 3A lanes 3 and 4). Similarly, the alcoholysis
mutants do not form circular dinucleotides in a buffer containing
Mg2+, and they produce somewhat less of the other products
than in Mn2+ (shown for mutants N117S and Q148S in figure
3A lanes 6 and 8), resulting in a much reduced overall cleavage
level.
Another way to prevent formation of circular dinucleotides is
changing the number of nucleotides that are cleaved off. We
therefore also tested substrates with either one, two, or three
nucleotides 3' of the conserved CA dinucleotide. Wild-type
HIV-2 IN efficiently cleaves all three substrates (figure 3B lane
2). However, the 3' hydroxyl end of substrates with one or three
nucleotides 3' of the CA dinucleotide can not be used as a
nucleophile (7). Again, the cleavage level of the alcoholysis
mutants was reduced, although less severely than in the cleavage
reactions with Mg2+ (figure 3B).
In conclusion, we identified a class of mutants that pre-
ferentially use the 3' hydroxyl group of the viral DNA as nucleo-
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Figure 3. Cleavage under conditions that do not allow formation of circular
dinucleotides. (A) Cleavage in the presence of Mn2+ (lanes 3, 5 and 7) or Mg2+
(lanes 4, 6 and 8) using wild-type HIV-2 IN Oanes 3 and 4), and the mutants
Nl 17S (lanes 5 and 6) and Q148S (lanes 7 and 8). Lane 1 shows a reaction without
IN, and lane 2 contains a DNaseI degradation ladder of the oligonucleotide. The
nomenclature is as in figure 1. (B) Cleavage of oligonucleotide substrates that
contain one (upper panel), two (middle panel) or three nucleotides (lower panel)
3' of the conserved CA-dinucleotide. Cleavage reactions without IN (lane 1),
with wild-type HIV-2 IN (lane 2), and the mutants N117S (lane 3) and Q148S
(lane 4) are shown. Substrates were labeled at the 5' end, the positions of the
substrates (29, 28, or 27) and the 26-mer cleavage products are indicated.
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Mutant Q148L produces more than 90% circular dinucleotides.
When the Gln- 148- Leu mutation is present in both the C-
terminal deletion mutant and the active-site mutant, the mixture
of these mutants produces almost exclusively circular
dinucleotides (figure 4 lane 12). To investigate whether the choice
of nucleophile is determined by the subunit that provides the active
site or by the one that contains the DNA-binding domain, we
mixed the C-terminal deletion mutant and the active-site mutant
in which the alcoholysis mutation was present only in the deletion
mutant (figure 4 lane 9) or the active-site mutant (lane 11). When
the alcoholysis mutation was present on the subunit that provides
the active site (in this case the C-terminal deletion mutant), the
mixture produced primarily circular dinucleotides, whereas the
other combination produced the three cleavage products in similar
amounts as wild-type HIV-2 IN, showing that the nucleophile
is selected by the subunit that provides the active site.
DISCUSSION
Figure 4. Complementation reactions between HIV-2 IN mutants containing
alcoholysis mutations. (A) Schematic representation of the various complementation
reactions. V = mutation Asp-64-Val (active-site mutation), L = mutation
Gln-148-Leu (alcoholysis mutation). The relative level of circular dinucleotides
is indicated; WT = relative amount of circular dinucleotides is similar to wild-
type HIV-2 IN, C = primarily circular dinucleotides are formed. (B) Cleavage
reactions containing wild-type HIV-2 IN (lane 3), the mutants Q148L (lane 4),
D64V (lane 5), CA73 (lane 6), CA73/Q148L (lane 8), and D64V/Q148L (lane
10), and the combinations of D64V and CA73 (lane 7), D64V and CA73/Q 148L
(lane 9), D64V/Q148L and CA73 (lane 11), and D64V/Q148L and CA73/Q148L
(lane 12). Lane 1 contains a reaction without IN, and lane 2 a DNaseI degradation
ladder of the oligonucleotide. A slash signifies the presence of two mutations
in the same protein molecule; further nomenclature as in figure 1.
phile in the cleavage reaction, and have a reduced cleavage
activity when this nucleophile can not be used.
The nucleophile is selected by the subunit that provides the
active site
HIV IN proteins mutated in different domains can complement
each other (19, 20). Presumably, mutant Cz\73 (in which the
C-terminal 73 amino acids have been deleted) contains the active
site, but does not bind DNA, whereas mutant D64V binds DNA,
but does not contain an intact active site. Both mutants alone do
not mediate site-specific cleavage. A mixture of these mutants,
however, is active: linear dinucleotides, glycerol adducts, and
circular dinucleotides are produced in similar relative amounts
as in the cleavage reaction with wild-type HIV-2 IN (figure 4
lane 7).
IN exposes a specific phosphodiester bond near the viral DNA
end to nucleophilic attack by water, glycerol, or the viral 3'
hydroxyl end. We here report the characterization of a class of
mutant IN proteins that produce more circular dinucleotides (the
result of nucleophilic attack by the 3' hydroxyl group) and less
of the other products. In addition, their cleavage activity in the
presence of Mg2+ is much reduced, presumably because
substitution of Mn2+ by Mg2+ prevents the formation of circular
dinucleotides.
A large variety of nucleophiles can be used in the IN-catalyzed
cleavage reaction, including glycerol, 1,2-ethanediol, L-serine,
water and the 3' hydroxyl group of the viral DNA molecule (6,7).
This variety of nucleophiles might suggest that IN only exposes
the phosphodiester bond and that it does not recognize the
nucleophile. However, a common feature of these nucleophiles
is that they have a hydroxyl group, which is used to attack the
phosphodiester bond. We here show that substitution of several
different amino acid residues leads to a change in the preference
for nucleophiles. The main difference is observed between the
soluble nucleophiles (water and glycerol) and the 3' hydroxyl
group of the viral DNA molecule. It is conceivable that soluble
nucleophiles must be presented by IN, whereas the 3' hydroxyl
group of the bound viral DNA is present near the phosphodiester
bond anyway. This would imply that the alcoholysis mutants
specify amino acids involved in presentation of the nucleophile.
Even mutants in which the size or the chemical properties of the
side-chain of the substituted amino acid are similar to those of
the wild-type residue (such as mutants S147A in HIV-2 IN or
Asn- 1 17- Gln in HIV-1 IN (9)), can lead to dramatic changes
in the choice of nucleophiles. This suggests that the changed
preference for nucleophiles is not caused by large changes in the
three-dimensional structure. These residues might be involved
in direct interactions with the nucleophile (thereby positioning
and/or activating it), as has been proposed for the exonuclease
action of E. coli DNA-polymerase I (23). Alternatively, they
might form a cleft into which the nucleophile must enter before
it can reach the phosphodiester bond. Small changes in the
composition of such a cleft might alter nucleophile selection. We
favor the first hypothesis, because nucleophiles that vary
significantly in size and chemical properties can attack the specific
phosphodiester bond.
In most mutational analyses cleavage assays were done in the
presence of unphysiologically high concentrations of Mn2+
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(instead of Mg2+). Substitution of Mg2+ for Mn2+ results in a
high preference for water over glycerol, and under these
conditions the 3' hydroxyl group is not used at all. As expected,
we found that the alcoholysis mutants then exhibit a very low
level of donor cut, suggesting that their preference for the 3'
hydroxyl group is caused by difficulties in recruiting soluble
nucleophiles. In other words, these mutants identify amino acids
that are probably required for efficient cleavage in vivo, where
primarily Mg2+ is present as divalent cation. The integration
efficiencies and target-site preferences of most mutants described
here are not altered (data not shown), suggesting that these
residues are only involved in presentation of soluble nucleophiles.
Several oligomeric proteins have a shared active site. For
example, the Flp recombinase in yeast provides three key catalytic
residues (that probably activate a specific phosphodiester bond)
on one subunit, and the active-site tyrosine residue (that leads
the nucleophilic attack) on separate subunit (24). We show that
the HIV IN subunit that provides the catalytic domain also
determines the choice of the nucleophile, which is in agreement
with the hypothesis that IN contains a single active site that is
not shared between different subunits.
22. Sambrook,J., Fritch,E.F., and Maniatis,T. (1989) Molecular cloning: A
laboratory manual, second edition. Cold Spring Harbor Laboratory Press,
Cold Spring Harbor, NY.
23. Beese,L.S., and Steitz,T.A. (1991) EMBO J., 10, 25-33.
24. Chen,J.W., Lee,J. and Jayaram,M. (1992) Cell, 69, 647-658.
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